Maetani Iruru, Isayama Hiroyuki, Mizumoto Yoshinori
Division of Gastroenterology, Department of Internal Medicine, Toho University Ohashi Medical Center, Tokyo, Japan.
Gastrointest Endosc. 2007 Aug;66(2):355-60. doi: 10.1016/j.gie.2006.11.060.
Through-the-scope (TTS) stents facilitate palliative enteral stent placement. However, most TTS stents are braided, a characteristic that has been associated with significant foreshortening and relatively frequent migration.
To evaluate clinical experience with a new woven enteral stent in the treatment of gastric outlet obstruction.
From January 2005 to August 2006, patients with unresectable malignant gastric outlet obstruction were offered stent placement with a new woven stent.
Three referral hospitals in Japan.
Thirty-seven consecutive patients with malignant gastric outlet obstruction.
A newly designed enteral stent was placed by using the TTS placement technique.
Palliation efficacy and safety of the new stents.
Stent placement was successful in 36 of 37 patients (technical success, 97%). Thirty-four patients were able to tolerate oral intake without obstructive symptoms (clinical success, 94.4%). Complications occurred in 16.2% of patients, comprising 2 cases of primary stent dysfunction, 1 perforation, 1 GI bleeding, 1 stent obstruction, and 1 biliary stent dysfunction. No migration was seen during the median follow-up period of 68 days.
Small sample size and relatively brief follow-up.
A newly developed enteral stent with higher flexibility and less foreshortening offers comparable clinical outcome to existing stents and a lower frequency of complications, including migration.
经内镜(TTS)支架有助于姑息性肠内支架置入。然而,大多数TTS支架是编织型的,这一特性与明显的缩短和相对频繁的移位有关。
评估一种新型编织肠内支架治疗胃出口梗阻的临床经验。
2005年1月至2006年8月,为不可切除的恶性胃出口梗阻患者提供新型编织支架置入治疗。
日本的三家转诊医院。
37例连续性恶性胃出口梗阻患者。
采用TTS置入技术放置一种新设计的肠内支架。
新型支架的缓解疗效和安全性。
37例患者中有36例成功置入支架(技术成功率97%)。34例患者能够耐受经口进食且无梗阻症状(临床成功率94.4%)。16.2%的患者出现并发症,包括2例原发性支架功能障碍、1例穿孔、1例胃肠道出血、1例支架梗阻和1例胆管支架功能障碍。在68天的中位随访期内未见移位。
样本量小且随访时间相对较短。
一种新开发的具有更高柔韧性和更少缩短的肠内支架,其临床疗效与现有支架相当,并发症发生率更低,包括移位。